John Samanich
Child & Adolescent Psychiatry · Armonk, NYNPI 1598819971
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.
Across 144 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$501
- Tris Pharma Inc$464
- Ironshore Pharmaceuticals Inc.$451
- Takeda Pharmaceuticals U.S.A., Inc.$278
- Supernus Pharmaceuticals, Inc.$179
- Otsuka America Pharmaceutical, Inc.$163
- plus $740 from 13 others
What the payments were for
- Food & beverage$2,75099%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 28 | $501 |
| Tris Pharma Inc | 36 | $464 |
| Ironshore Pharmaceuticals Inc. | 16 | $451 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $278 |
| Supernus Pharmaceuticals, Inc. | 8 | $179 |
| Otsuka America Pharmaceutical, Inc. | 9 | $163 |
| E.r. Squibb & Sons, L.L.C. | 6 | $155 |
| Neos Therapeutics, LP | 4 | $80 |
| AbbVie | 3 | $80 |
| Alfasigma USA, Inc. | 4 | $77 |
| Shire North American Group Inc | 3 | $60 |
| Adlon Therapeutics L.p. | 3 | $49 |
| Lundbeck LLC | 2 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $46 |
| Vertical Pharmaceuticals, LLC | 2 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Harmony Biosciences LLC | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JORNAY PM$124
How this compares
$2,777 in reported general payments places this provider in the 85th percentile of 317 child & adolescent psychiatry providers in New York.
See all child & adolescent psychiatry providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexmethylphenidate Hcl | 12 | $605 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $392 |
| Clonazepam | 15 | $88 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Armonk
- Matthew LorberNew York$398K
- Mitchell CabisudoNew Windsor$346K
- Parinda ParikhWhite Plains$185K
- Jeffrey NewcornNew York$165K
- John MarinoCanandaigua$70K
- Iliyan IvanovNew York$38K
- Melvin OatisNew York$35K
- Vijay PampanaMiddletown$19K
- Marc ReitmanHuntington$13K
- Marie CharlesBrooklyn$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.